Active, not recruitingPHASE1, PHASE2NCT04432597

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Studying Carcinoma of the anal canal

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Charalampos Floudas, M.D.
National Cancer Institute (NCI)
Intervention
PRGN-2009(biological)
Enrollment
39 enrolled
Eligibility
18 years · All sexes
Timeline
20202026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04432597 on ClinicalTrials.gov

Other trials for Carcinoma of the anal canal

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the anal canal

← Back to all trials